PRF Reaches $1.4 of the $2 Million Needed to Fund Trial! In July, UCLA researchers Loren Fong and Stephen Young published findings from PRF-funded studies with Progeria mice, testing a potential drug treatment for children with Progeria. The FTI drug improved some...
PRF-funded, UCLA researchers have taken a Progeria-like mouse model and tested a potential drug treatment for children with Progeria. Their study released in Science Feb.16th has found that this FTI drug improves some signs of the disease. In September The Progeria...
Proceedings National Academy of Sciences, July 2005 * By Shao H. Yang, Julia I. Toth, Yan Hu, Salemiz Sandoval, Stephen G. Young, and Loren G. Fong, David Geffen School of Medicine, UCLA; Margarita Meta, University of California, San Francisco; Pravin Bendale and...
Cells from patients with Hutchinson-Gilford Progeria Syndrome (HGPS) can be made healthy again, according to findings by scientists at the National Cancer Institute, part of the National Institutes of Health. Published online on March 6, 2005 in Nature Medicine...
Reporter Christine Haran provides a top-line overview of Progeria and the current research findings reported in Nature and Journal of Pediatrics. Reporter Christine Haran provides a top-line overview of Progeria and the current research findings reported in Nature and...
August 2005 –February 2006: Researchers have published studies that support a potential drug treatment for children with Progeria. Farnesyltransferase inhibitors (FTIs), originally developed for cancer, are capable of reversing the dramatic nuclear structure...
English 
Arabic 
Bengali 
Chinese 
Dutch 
French 
German 
Hebrew 
Hindi 
Indonesian 
Italian 
Kannada 
Kazakh 
Korean 
Marathi 
Pashto 
Portuguese 
Russian 
Spanish 
Tamil 
Ukrainian 
Urdu